Previous close | 0.3160 |
Open | 0.3360 |
Bid | 0.2740 x N/A |
Ask | 0.3120 x N/A |
Day's range | 0.3360 - 0.3360 |
52-week range | 0.2460 - 1.4500 |
Volume | |
Avg. volume | 79 |
Market cap | 2.672M |
Beta (5Y monthly) | 2.39 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
ADC Therapeutics (ADCT) delivered earnings and revenue surprises of 0% and 0.75%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
We feel now is a pretty good time to analyse ThermoGenesis Holdings, Inc.'s ( NASDAQ:THMO ) business as it appears the...
Key Insights ThermoGenesis Holdings will host its Annual General Meeting on 14th of December Salary of US$519.0k is...